James E Flynn Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James E Flynn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James E Flynn. James E Flynn is a 10% Owner in CAS MEDICAL SYSTEMS INC ($CAMY.OB) and a 10% Owner in AxoGen, Inc. ($LECT) and a 10% Owner in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and a 10% Owner in Fibrocell Science, Inc. ($FCSC) and a 10% Owner in STREAMLINE HEALTH SOLUTIONS INC. ($LANV) and a 10% Owner in ANTARES PHARMA, INC. ($ATRS) and a 10% Owner in VIA Pharmaceuticals, Inc. ($CAQ) and a 10% Owner in DUSA PHARMACEUTICALS INC ($DUSA) and a 10% Owner in HI TECH PHARMACAL CO INC ($HITK) and a 10% Owner in AVADEL PHARMACEUTICALS PLC ($AVDL) and a 10% Owner in INSPIRE PHARMACEUTICALS INC ($ISPH) and a 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and a 10% Owner in ARENA PHARMACEUTICALS INC ($ARNA) and a 10% Owner in ISTA PHARMACEUTICALS INC ($ISTA) and a 10% Owner in MEDICINES CO /DE ($MDCO) and a 10% Owner in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and a 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and a 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and a Director in Talon Therapeutics, Inc. ($EMLR) and a 10% Owner in LUMOS PHARMA, INC. ($NLNK) and a 10% Owner in NITROMED INC ($NTMD) and a 10% Owner in XENOPORT INC ($XNPT) and a 10% Owner in EMAGEON INC ($EMAG) and a 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and a 10% Owner in ALIMERA SCIENCES INC ($ALIM) and a 10% Owner in NeuroMetrix, Inc. ($NURO) and a 10% Owner in NxStage Medical, Inc. ($NXTM) and a 10% Owner in aTYR PHARMA INC ($LIFE) and a 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and a 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and a Director in PROTEON THERAPEUTICS INC ($PRTO) and a 10% Owner in eHealth, Inc. ($EHTH) and a 10% Owner in ZAFGEN, INC. ($ZFGN) and a 10% Owner in NeurogesX Inc ($NGSX) and a 10% Owner in Invuity, Inc. ($IVTY) and a 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and a 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and a 10% Owner in TriVascular Technologies, Inc. ($TRIV) and a 10% Owner in Auspex Pharmaceuticals, Inc. ($ASPX) and a 10% Owner in Neos Therapeutics, Inc. ($NEOS) and a 10% Owner in Schrodinger, Inc. ($SDGR) and a 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and a Director in Acutus Medical, Inc. ($AFIB) and a 10% Owner in Annexon, Inc. ($ANNX) and a 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and a 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and a 10% Owner in Mallinckrodt plc ($MNK) and a 10% Owner in Loxo Oncology, Inc. ($LOXO) and a 10% Owner in Adverum Biotechnologies, Inc. ($AAVL) and a 10% Owner in REGENXBIO Inc. ($RGNX) and a 10% Owner in Recro Pharma, Inc. ($REPH) and a 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and a Director in Nivalis Therapeutics, Inc. ($NVLS) and a 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and a 10% Owner in SteadyMed Ltd. ($STDY) and a 10% Owner in ShockWave Medical, Inc. ($SWAV) and a 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and a 10% Owner in Editas Medicine, Inc. ($EDIT) and a Director in AveXis, Inc. ($AVXS) and a 10% Owner in ARVINAS INC. ($ARVN) and a 10% Owner in Homology Medicines, Inc. ($FIXX) and a Director in Homology Medicines, Inc. ($FIXX) and a Director in Oncorus, Inc. ($ONCR) and a 10% Owner in Revolution Medicines, Inc. ($RVMD) and a 10% Owner in Black Diamond Therapeutics, Inc. ($BDTX) and a 10% Owner in Frequency Therapeutics, Inc. ($FREQ) and a Director in DFB Healthcare Acquisitions Corp. ($DFBH) and a 10% Owner in Generation Bio Co. ($GBIO) and a 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and a 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and a 10% Owner in Cabaletta Bio, Inc. ($CABA) and a 10% Owner in Werewolf Therapeutics, Inc. ($HOWL) and a 10% Owner in Nkarta, Inc. ($NKTX) and a 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and a Director in DFP HEALTHCARE ACQUISITIONS CORP. ($DFPH) and a Director in Deerfield Healthcare Technology Acquisitions Corp. ($DFHT) and a 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).
Address: 780 THIRD AVENUE 37TH FLOOR NEW YORK 10017 NY
Companies in which James E Flynn is an Insider
Aclaris Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 964,101 shares
Current Value: $24,343,550
Latest Transaction: Jul 01 2019
$ACRS Market Capitalization: $537.94M
$ACRS Previous Close: $25.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Acutus Medical, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of James E Flynn: Director
Holdings: 2,222 shares
Latest Transaction: Aug 12 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AdaptHealth Corp.
Industry: SERVICES-HOME HEALTH CARE SERVICES [8082]
Position of James E Flynn: Director
Holdings: 14,900,000 shares
Latest Transaction: Nov 13 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Adverum Biotechnologies, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: 10% Owner
Holdings: 627,267 shares
Latest Transaction: Aug 05 2014
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ALIMERA SCIENCES INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 728,718 shares
Current Value: $845,313
Latest Transaction: Dec 08 2015
$ALIM Market Capitalization: $75.24M
$ALIM Previous Close: $1.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ALPINE IMMUNE SCIENCES, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: Director, 10% Owner
Holdings: 832,216 shares
Current Value: $1,947,385
Latest Transaction: Sep 14 2016
$ALPN Market Capitalization: $36.22M
$ALPN Previous Close: $2.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Annexon, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 458,914 shares
Latest Transaction: Jul 28 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ANTARES PHARMA, INC.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of James E Flynn: 10% Owner
Holdings: 5,348,776 shares
Current Value: $11,767,307
Latest Transaction: Sep 30 2015
$ATRS Market Capitalization: $356.70M
$ATRS Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARENA PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 3,238,908 shares
Current Value: $4,825,973
Latest Transaction: Oct 23 2007
$ARNA Market Capitalization: $357.67M
$ARNA Previous Close: $1.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARVINAS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 307,078 shares
Latest Transaction: Oct 01 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
aTYR PHARMA INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: 10% Owner
Holdings: 255,764 shares
Current Value: $869,598
Latest Transaction: May 13 2015
$LIFE Market Capitalization: $78.27M
$LIFE Previous Close: $3.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Audentes Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: 10% Owner
Holdings: 535,996 shares
Current Value: $8,484,817
Latest Transaction: Jul 25 2016
$BOLD Market Capitalization: $337.82M
$BOLD Previous Close: $15.83
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Auspex Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 0 shares
Latest Transaction: May 07 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AVADEL PHARMACEUTICALS PLC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 952,265 shares
Latest Transaction: Jun 25 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AveXis, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: Director
Holdings: 112,000 shares
Current Value: $6,602,400
Latest Transaction: Feb 19 2016
$AVXS Market Capitalization: $1.59B
$AVXS Previous Close: $58.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Axogen, Inc.
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of James E Flynn: 10% Owner
Holdings: 3,000,000 shares
Latest Transaction: Jul 21 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Black Diamond Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: 10% Owner
Holdings: 378,790 shares
Latest Transaction: Feb 03 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cabaletta Bio, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: 10% Owner
Holdings: 464,253 shares
Latest Transaction: Oct 30 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CAS MEDICAL SYSTEMS INC
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of James E Flynn: 10% Owner
Holdings: 2,947,554 shares
Latest Transaction: Jan 26 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CATALYST BIOSCIENCES, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,171,839 shares
Current Value: $691,385
Latest Transaction: Mar 08 2018
$CBIO Market Capitalization: $6.51M
$CBIO Previous Close: $0.59
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CONSTELLATION PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 635,843 shares
Latest Transaction: Jul 23 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cyclacel Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 881,743 shares
Latest Transaction: Nov 20 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CytomX Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 275,000 shares
Current Value: $3,162,500
Latest Transaction: Oct 14 2015
$CTMX Market Capitalization: $410.61M
$CTMX Previous Close: $11.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Deerfield Healthcare Technology Acquisitions Corp.
Industry: SERVICES-NURSING & PERSONAL CARE FACILITIES [8050]
Position of James E Flynn: Director
Holdings: 3,360,000 shares
Latest Transaction: Jul 22 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
DFP HEALTHCARE ACQUISITIONS CORP.
Industry: BLANK CHECKS [6770]
Position of James E Flynn: Director
Holdings: 2,500,000 shares
Latest Transaction: Mar 17 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Dicerna Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 972,642 shares
Current Value: $2,509,416
Latest Transaction: Feb 04 2014
$DRNA Market Capitalization: $50.84M
$DRNA Previous Close: $2.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
DUSA PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,952,648 shares
Latest Transaction: Jun 26 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
DYNAVAX TECHNOLOGIES CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 24 2008
$DVAX Market Capitalization: $154.11M
$DVAX Previous Close: $3.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Edgewise Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,572,960 shares
Latest Transaction: Mar 30 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Editas Medicine, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: 10% Owner
Holdings: 954,700 shares
Current Value: $17,719,232
Latest Transaction: Feb 08 2016
$EDIT Market Capitalization: $636.78M
$EDIT Previous Close: $18.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
eHealth, Inc.
Industry: INSURANCE AGENTS BROKERS & SERVICES [6411]
Position of James E Flynn: 10% Owner
Holdings: 428,367 shares
Current Value: $4,917,653
Latest Transaction: Apr 27 2017
$EHTH Market Capitalization: $204.50M
$EHTH Previous Close: $11.48
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
EMAGEON INC
Industry: SERVICES-PREPACKAGED SOFTWARE [7372]
Position of James E Flynn: 10% Owner
Holdings: 1,173,658 shares
Latest Transaction: Mar 02 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Fibrocell Science, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,162,800 shares
Current Value: $813,960
Latest Transaction: Aug 18 2010
$FCSC Market Capitalization: $30.78M
$FCSC Previous Close: $0.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Frequency Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 472,860 shares
Latest Transaction: Oct 07 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Generation Bio Co.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 703,332 shares
Latest Transaction: Jun 16 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HI TECH PHARMACAL CO INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 346,016 shares
Latest Transaction: Dec 13 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Homology Medicines, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner, Director
Holdings: 509,970 shares
Latest Transaction: Jan 31 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INSPIRE PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 2,307,449 shares
Latest Transaction: May 02 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Invuity, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of James E Flynn: 10% Owner
Holdings: 1,807,239 shares
Current Value: $12,650,673
Latest Transaction: Dec 14 2016
$IVTY Market Capitalization: $117.66M
$IVTY Previous Close: $7.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ISTA PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 551,099 shares
Latest Transaction: May 06 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kiniksa Pharmaceuticals, Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 383,538 shares
Latest Transaction: May 31 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Larimar Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 247,413 shares
Current Value: $1,014,393
Latest Transaction: Aug 01 2016
$LRMR Market Capitalization: $109.05M
$LRMR Previous Close: $4.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Loxo Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 296,125 shares
Current Value: $11,756,163
Latest Transaction: Aug 06 2014
$LOXO Market Capitalization: $860.18M
$LOXO Previous Close: $39.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LUMOS PHARMA, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 908,183 shares
Current Value: $12,414,862
Latest Transaction: Jan 08 2021
$NLNK Market Capitalization: $408.17M
$NLNK Previous Close: $13.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Mallinckrodt plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 8,510,461 shares
Current Value: $431,310,163
Latest Transaction: May 10 2018
$MNK Market Capitalization: $5.32B
$MNK Previous Close: $50.68
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MEDICINES CO /DE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 3,035,472 shares
Current Value: $140,542,354
Latest Transaction: Apr 06 2011
$MDCO Market Capitalization: $3.32B
$MDCO Previous Close: $46.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Mirum Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,558,456 shares
Latest Transaction: Jul 24 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Neos Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 429,166 shares
Current Value: $2,145,830
Latest Transaction: Jul 28 2015
$NEOS Market Capitalization: $81.10M
$NEOS Previous Close: $5.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NeurogesX Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 987,880 shares
Latest Transaction: Jul 15 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NeuroMetrix, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of James E Flynn: 10% Owner
Holdings: 781,833 shares
Current Value: $539,465
Latest Transaction: Dec 14 2010
$NURO Market Capitalization: $3.81M
$NURO Previous Close: $0.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NITROMED INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 46,085,133 shares
Latest Transaction: Apr 27 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Nkarta, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 709,936 shares
Latest Transaction: Jul 14 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NxStage Medical, Inc.
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of James E Flynn: 10% Owner
Holdings: 1,292,874 shares
Current Value: $35,916,040
Latest Transaction: Dec 15 2009
$NXTM Market Capitalization: $1.80B
$NXTM Previous Close: $27.78
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Oncorus, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: Director
Holdings: 620,480 shares
Latest Transaction: Oct 08 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PAR PHARMACEUTICAL COMPANIES, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 2,173,177 shares
Latest Transaction: Feb 01 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Protara Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: Director
Holdings: 197,424 shares
Current Value: $384,977
Latest Transaction: Jun 12 2018
$TARA Market Capitalization: $31.94M
$TARA Previous Close: $1.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Recro Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,277,132 shares
Current Value: $10,280,913
Latest Transaction: Jun 14 2017
$REPH Market Capitalization: $98.40M
$REPH Previous Close: $8.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
REGENXBIO Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: 10% Owner
Holdings: 49,000 shares
Current Value: $840,350
Latest Transaction: Sep 22 2015
$RGNX Market Capitalization: $465.96M
$RGNX Previous Close: $17.15
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Revolution Medicines, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: 10% Owner
Holdings: 997,589 shares
Latest Transaction: Feb 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RHYTHM PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 291,005 shares
Latest Transaction: Oct 10 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RIGEL PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 3,204,167 shares
Current Value: $7,850,209
Latest Transaction: Jun 07 2011
$RIGL Market Capitalization: $237.45M
$RIGL Previous Close: $2.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Schrodinger, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,346,167 shares
Latest Transaction: Feb 10 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Shockwave Medical, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of James E Flynn: 10% Owner
Holdings: 132,740 shares
Latest Transaction: Mar 11 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SteadyMed Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 823,529 shares
Current Value: $2,552,940
Latest Transaction: Mar 25 2015
$STDY Market Capitalization: $68.47M
$STDY Previous Close: $3.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
STREAMLINE HEALTH SOLUTIONS INC.
Industry: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
Position of James E Flynn: 10% Owner
Holdings: 1,875,500 shares
Latest Transaction: Dec 17 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Syros Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,186,654 shares
Current Value: $12,958,262
Latest Transaction: Jul 06 2016
$SYRS Market Capitalization: $249.93M
$SYRS Previous Close: $10.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Talon Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: Director
Holdings: 0 shares
Latest Transaction: Jul 18 2013
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Terns Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,717,033 shares
Latest Transaction: Feb 09 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
THIRD WAVE TECHNOLOGIES INC /WI
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: 10% Owner
Holdings: 734,795 shares
Latest Transaction: May 22 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TriVascular Technologies, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of James E Flynn: 10% Owner
Holdings: 261,143 shares
Latest Transaction: Apr 22 2014
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Vanda Pharmaceuticals Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,873,108 shares
Current Value: $25,567,924
Latest Transaction: Sep 26 2016
$VNDA Market Capitalization: $628.43M
$VNDA Previous Close: $13.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VIA Pharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James E Flynn: 10% Owner
Holdings: 1,244,708 shares
Latest Transaction: Nov 07 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Werewolf Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 1,752,787 shares
Latest Transaction: May 04 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
XENOPORT INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 2,746,650 shares
Latest Transaction: Feb 23 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
XERIS PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 857,821 shares
Latest Transaction: Feb 12 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of James E Flynn
Sentiment: All, ACRS, AFIB, DFBH, ADVM, ALIM, ALPN, ANNX, ATRS, ARNA, ARVN, LIFE, BOLD, ASPX, AVDL, AVXS, LECT, BDTX, CABA, CAMY.OB, CBIO, CNST, CYCC, CTMX, DFHTW, DFPHU, DRNA, DUSA, DVAX, EWTX, EDIT, EHTH, EMAG, FCSC, FREQ, GBIO, HITK, FIXX, ISPH, IVTY, ISTA, KNSA, LRMR, LOXO, NLNK, MNK, MDCO, MIRM, NEOS, NGSX, NURO, NTMD, NKTX, NXTM, ONCR, PRX, TARA, REPH, RGNX, RVMD, RYTM, RIGL, SDGR, SWAV, STDY, LANV, SYRS, EMLR, TERN, TWTI, TRIV, VNDA, CAQ, HOWL, XNPT, XERS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 04 2021 | HOWL | Werewolf Therapeut ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 15,195,094 | 0 | 0 | |
| May 04 2021 | HOWL | Werewolf Therapeut ... | Flynn James E | 10% Owner | Buy | P | 16.00 | 800,000 | 12,800,000 | 2,552,787 | 1.8 M to 2.6 M (+45.64 %) |
| May 04 2021 | HOWL | Werewolf Therapeut ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 1,752,787 | 0 | 1,752,787 | 0 to 1.8 M |
| Mar 30 2021 | EWTX | Edgewise Therapeut ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 433,551 | 0 | 0 | |
| Mar 30 2021 | EWTX | Edgewise Therapeut ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 1,301,626 | 0 | 0 | |
| Mar 30 2021 | EWTX | Edgewise Therapeut ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 1,572,960 | 0 | 0 | |
| Mar 30 2021 | EWTX | Edgewise Therapeut ... | Flynn James E | 10% Owner | Buy | P | 16.00 | 625,000 | 10,000,000 | 3,933,137 | 3.3 M to 3.9 M (+18.89 %) |